Regulation of human penile smooth muscle tone by prostanoid receptors

被引:64
作者
Angulo, J
Cuevas, P
La Fuente, JM
Pomerol, JM
Ruiz-Castañé, E
Puigvert, A
Gabancho, S
Fernández, A
Ney, P
de Tejada, IS
机构
[1] Fdn Invest & Desarrollo Androl, Madrid, Spain
[2] Hosp Ramon y Cajal, Dept Invest, E-28034 Madrid, Spain
[3] Schwarz Pharma AG, Corp Dev, D-4019 Monheim, Germany
关键词
prostanoid receptors; human corpus cavernosum; human penile resistance arteries; impotence;
D O I
10.1038/sj.bjp.0704675
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have characterized the prostanoid receptors involved in the regulation of human penile arterial and trabecular smooth muscle tone. 2 Arachidonic acid induced relaxation of human corpus cavernosum strips (HCCS) that was blocked by the cyclo-oxygenase inhibitor, indomethacin, and augmented by the thromboxane receptor (TP) antagonist, SQ29548, suggesting that endogenous production of prostanoids regulates penile smooth muscle tone. 3 TP-receptors mediate contraction of HCCS and penile resistance arteries (HPRA), since the agonist of these receptors. U46619, potently contracted HCCS (EC50 8.3 +/- 2.8 nM) and HPRA (EC50 6.2 +/- 2.2 nM), and the contractions produced by prostaglandin F-2alpha at high concentrations (EC50 6460 +/- 3220 nM in HCCS and 8900 +/- 6700 nM in HPRA) were inhibited by the selective TP-receptor antagonist, SQ29548 (0.02 muM). 4 EP-receptors are responsible for prostanoid-induced relaxant effects in HCCS because only prostaglandin E-1 (PGE(1)), prostaglandin E-2 and the EP2/EP4-receptor agonist, butaprost, produced consistent relaxation of this tissue (EC50) 93.8 +/- 31.5, 16.3 +/- 3.8 and 1820 +/- 1284 nM, respectively). In HPRA, both prostacyclin and PGE(1) (EC50) 60.1 +/- 18.4 and 109.0 +/- 30.9 nM, respectively) as well as the selective IP receptor agonist. cicaprost. and butaprost (EC50 25.2 +/- 5.2 and 7050 +/- 6020 nM, respectively) caused relaxation. suggesting co-existence of IP- and EP-receptors (EP- and or EP-). 5 In summary. endogenous production of prostanoids may regulate penile smooth muscle contractility by way of specific receptors. TP-receptors mediate contraction in HCCS and HPRA, while the relaxant effects of prostanoids are mediated by EP2- and/or EP4-receptors in HCCS and by EP- and IP-receptors in HPRA.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 44 条
[1]   The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs [J].
Abramovitz, M ;
Adam, M ;
Boie, Y ;
Carrière, MC ;
Denis, D ;
Godbout, C ;
Lamontagne, S ;
Rochette, C ;
Sawyer, N ;
Tremblay, NM ;
Belley, M ;
Gallant, M ;
Dufresne, C ;
Gareau, Y ;
Ruel, R ;
Juteau, H ;
Labelle, M ;
Ouimet, N ;
Metters, KM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1483 (02) :285-293
[2]   ENDOTHELIUM-DERIVED NITRIC-OXIDE AND CYCLOOXYGENASE PRODUCTS MODULATE CORPUS CAVERNOSUM SMOOTH-MUSCLE TONE [J].
AZADZOI, KM ;
KIM, N ;
BROWN, ML ;
GOLDSTEIN, I ;
COHEN, RA ;
DETEJADA, IS .
JOURNAL OF UROLOGY, 1992, 147 (01) :220-225
[3]   CHARACTERIZATION OF THE PROSTANOID RECEPTORS MEDIATING CONSTRICTION AND RELAXATION OF HUMAN ISOLATED UTERINE ARTERY [J].
BAXTER, GS ;
CLAYTON, JK ;
COLEMAN, RA ;
MARSHALL, K ;
SANGHA, R ;
SENIOR, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (01) :1692-1696
[4]  
BUNCE KT, 1990, ADV PROSTAGLANDIN TH, V21, P379
[5]   Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype [J].
Castleberry, TA ;
Lu, BH ;
Smock, SL ;
Owen, TA .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 65 (04) :167-187
[6]   Prostanoid-induced contraction of the rabbit isolated uterus is mediated by FP receptors [J].
Chen, J ;
Woodward, DF ;
Yuan, YD ;
Marshall, K ;
Senior, J .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1998, 55 (5-6) :387-394
[7]   PROSTANOID-INDUCED CONTRACTION OF HUMAN BRONCHIAL SMOOTH-MUSCLE IS MEDIATED BY TP-RECEPTORS [J].
COLEMAN, RA ;
SHELDRICK, RLG .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (03) :688-692
[8]   A NOVEL INHIBITORY PROSTANOID RECEPTOR IN PIGLET SAPHENOUS-VEIN [J].
COLEMAN, RA ;
GRIX, SP ;
HEAD, SA ;
LOUTTIT, JB ;
MALLETT, A ;
SHELDRICK, RLG .
PROSTAGLANDINS, 1994, 47 (02) :151-168
[9]  
COLEMAN RA, 1994, PHARMACOL REV, V46, P205
[10]  
COLEMAN RA, 1987, PROSTAGLANDINS RELAT, P267